Close
Close
People News

Mustang Bio to Present at 11th Annual Bioprocessing Summit

4.33333333333
4.3 from 3 votes
Tuesday, August 13, 2019

NEW YORK - Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that Knut Niss, Ph.D., Chief Technology Officer, will deliver a presentation at the 11th Annual Bioprocessing Summit, to be held August 12-16, 2019, in Boston.

The presentation titled "The Impact of Facility Design on the Cost of Goods in Autologous Cell Therapy" is part of the Commercializing CAR Ts – Allogeneic and Autologous track and will be held on Wednesday, August 14, 2019, at 9:30 a.m. EDT.

For additional information on the meeting, please visit: http://www.bioprocessingsummit.com/cell-therapy-bioproduction/.

About Mustang Bio
Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Mustang aims to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest, to fund research and development, and to outlicense or bring the technologies to market. Mustang has partnered with top medical institutions to advance the development of CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, as well as a lentiviral gene therapy for X­SCID. Mustang is registered under the Securities Exchange Act of 1934, as amended, and files periodic reports with the U.S. Securities and Exchange Commission. Mustang was founded by Fortress Biotech, Inc. (NASDAQ: FBIO). For more information, visit www.mustangbio.com.

Company Contacts:
Jaclyn Jaffe and William Begien
Mustang Bio, Inc.
(781) 652-4500
ir@mustangbio.com

Investor Relations Contact:
Daniel Ferry
LifeSci Advisors, LLC
(617) 535-7746
daniel@lifesciadvisors.com

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 940-0135
tplohoros@6degreespr.com

Source: Mustang Bio, Inc.
4.33333333333
4.3 from 3 votes
Free Newsletter
Videos